Bp PLC Dexcom Inc Transaction History

Bp PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$106.71 - $143.18 $242,445 - $325,304	-2,272 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$80.99 - $107.93 $73,376 - $97,784	-906 Reduced 28.51%	2,272 $970,000
Q1 2021 May 13, 2021	SELL	$84.79 - $104.74 $65,881 - $81,382	-777 Reduced 19.65%	3,178 $1.14 Million
Q4 2020 Feb 08, 2021	SELL	$78.0 - $104.5 $2.57 Million - $3.44 Million	-32,890 Reduced 89.27%	3,955 $1.46 Million
Q3 2020 Oct 30, 2020	BUY	$95.51 - $112.95 $2.61 Million - $3.09 Million	27,345 Added 287.84%	36,845 $15.2 Million
Q3 2019 Nov 13, 2019	BUY	$35.53 - $43.8 $337,535 - $416,100	9,500 New	9,500 $1.42 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Bp PLC, based on Form 13F filings with the SEC.

Stay updated on Bp PLC with notifications on news.